Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial.
Andrew H WeiHartmut DöhnerHamid SayarFarhad RavandiPau MontesinosHervé DombretDominik SelleslagKimmo PorkkaJun-Ho JangBarry SkikneC L BeachThomas PrebetGeorge ZhangAlberto RisueñoManuel UgidosWendy L SeeDaniel MenezesGail J RobozPublished in: American journal of hematology (2023)
Keyphrases
- acute myeloid leukemia
- placebo controlled
- phase iii
- double blind
- phase ii
- study protocol
- clinical trial
- allogeneic hematopoietic stem cell transplantation
- open label
- phase ii study
- locally advanced
- disease activity
- ulcerative colitis
- randomized controlled trial
- systemic lupus erythematosus
- squamous cell carcinoma
- chemotherapy induced
- rectal cancer
- acute lymphoblastic leukemia